Literature DB >> 393520

Once daily administration of sustained release propranolol capsules in the treatment of angina pectoris.

H Halkin, I Vered, A Saginer, B Rabinowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 393520     DOI： 10.1007/bf00568198

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  11 in total

1.  Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.

Authors:  M Pine; L Favrot; S Smith; K McDonald; C A Chidsey
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

Review 2.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

Review 3.  A review of medication errors and compliance in ambulant patients.

Authors:  R B Stewart; L E Cluff
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

4.  Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.

Authors:  C R Cleaveland; D G Shand
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

5.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

6.  Pharmacokinetic and pharmacodynamic studies with long-acting propranolol.

Authors:  J McAinsh; N S Baber; R Smith; J Young
Journal:  Br J Clin Pharmacol       Date:  1978-08       Impact factor: 4.335

7.  Propranolol serum levels during twenty-four hours.

Authors:  E Vervloet; B F Pluym; J Cilissen; K Köhlen; F W Merkus
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

8.  Efficacy of beta adrenergic blockade in coronary heart disease: propranolol in angina pectoris.

Authors:  R R Miller; H G Olson; C M Pratt; E Z Amsterdam; D T Mason
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875

9.  Dose response effectiveness of propranolol for the treatment of angina pectoris.

Authors:  E L Alderman; R O Davies; J J Crowley; M G Lopes; J Z Brooker; J P Friedman; A F Graham; H J Matlof; D C Harrison
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

10.  Propranolol in hypertensive dialysis patients: efficacy and compliance.

Authors:  W A Briggs; D T Lowenthal; W J Cirksena; W E Price; T P Gibson; W Flamenbaum
Journal:  Clin Pharmacol Ther       Date:  1975-11       Impact factor: 6.875
View more
  4 in total

Review 1.  Oral controlled release dosage forms. A review.

Authors:  P De Haan; C F Lerk
Journal:  Pharm Weekbl Sci       Date:  1984-04-27

2.  Interindividual variations in metoprolol metabolism--some clinical and other observations.

Authors:  C G Regårdh; G Johnsson
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

Review 3.  Pharmacokinetics of long acting propranolol. Implications for therapeutic use.

Authors:  G S Nace; A J Wood
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

4.  Comparison of once and twice daily sotalol in exercise-induced angina pectoris.

Authors:  C Wilhelmsson; A Vedin; G Ulvenstam; A Aberg; R Descamps; J A Thomis
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.